Los mejores oncohematólogos de Quimioterapia contra la leucemia — TOP-91 médicos
Education
- Ege Faculty of Medicine 1978
- Specialization in Pediatrics 1982
- Subspecialty Pediatric Oncology 2002 (EU Faculty of Medicine)
- Pediatric Hematology and Oncology 2012 (EU Faculty of Medicine)
- Deputy Chief of Clinic 1988 Tepecik EAH
- Clinical Chief 1993 Tepecik EAH
- Associate Professorship 1995
- Professorship 2002
- Ege U. Faculty of Medicine, faculty member 1998 – 2022
- EU Faculty of Medicine Department of Pediatrics 2009-2018
- Member of Tepecik Education Planning and Coordination Board (1993-1998)
- SSI Tepecik Hospital Ethics Committee Chairman (1996-1998)
- Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group Co-Chair" (2002-2006)
- Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group" (2006-2008)
- Turkish Society of Pediatric Hematology - Responsible for Bone Marrow Transplantation "Online" Data Registry System 2007-ongoing.
- Ege University Regenerative Medicine and Stem Cell Commission Chairman, 2011-2021
Institutional Memberships
- Turkish Medical Association İzmir and Kocaeli Branch
- Turkish National Pediatric Association - İzmir
- European Group for Bone Marrow Transplantation (EBMT); Ege University Pediatric Bone Marrow Transplantation Unit was accredited by the European Group for Bone Marrow Transplantation (EBMT) in June 2007.
- Turkish Society of Pediatric Hematology - Board Member for two terms (2005-2009)
- Turkish Society of Hematology - Board Member for two terms (2001/2005)
- Turkish Pediatric Oncology Association
- Bone Marrow Transplantation Foundation (KITVAK) Member of the Board of Trustees
Units he is the founder of
1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990)
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992)
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998)
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.
Transplantation units that he contributed to the establishment of
1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019)
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020)
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)
Awards
- Thrombotic parameters in bone marrow stem cell transplant patients, Pediatric Hematology Congress, Trabzon 2003
- CD133 Antigen in Stem Cell: Pediatric Hematology Congress 2005. Research award
- The role of Toll like receptors in febrile neutropenic patients, Best poster award. Turkish Hematology Congress 2008, Çeşme-İzmir
- National pediatric stem cell transplantation activity- Oral presentation second prize, Turkish Hematology Society Stem Cell Transplantation Congress, 2022, Antalya
Publications
Kansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir
Kansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir
Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5
Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003
Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005
Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008
Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009
Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017
Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017
Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017
11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999. (1.05 points)
Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)
Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003.
Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016
Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017
Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020
National pediatric stem cell transplant activity, 2020
Childhood stem cell transplantation indications, Turkey Clinics - International book 2020
In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.
Mostrar másUndergraduate and Doctoral Education:
* 1992-1999 Ondokuz Mayıs University Faculty of Medicine
* 2002-2007 Inonu University, Faculty of Medicine, Child Health and Diseases,
Pediatrics Residency
* 2015-2018 Inonu University, Faculty of Medicine, Pediatrics, Pediatric
Hematology and Oncology Subspecialization
*2017-Ankara University, Pediatrics, Oncology minor residency (8 months)
Mostrar másEducación
Facultad de Medicina: Universidad Ben Gurion
Especialización
- Medicina Interna - en el Centro Médico Sapir - Kfar Saba
- Hematología - Centro Médico Sourasky Tel Aviv
Experiencia Reconocido
Medicina Interna y Hematología
Educación adicional
NHLBI/NIH, Bethesda, EE. UU.
Experiencia clínica
- Médico senior del sistema hematológico de 2004 a 2006, 2008
- Director de la Clínica de Hematología de 2010 a 2014, 2017
- Gerente de Servicio CLL de 2013 a 2018
- Director del bloque CLL a partir de 2018
- Secretario del Grupo CLL de Israel desde 2016.
Experiencia academica
- Profesor Titular de Hematología - Universidad de Tel Aviv (2013-2018)
- Profesor Asociado de Hematología - Universidad de Tel Aviv (2018)
Publicaciones profesionales
Más de 80 publicaciones profesionales
Membresía de la unión
- Asociación Hematológica Israelí
- Asociación Americana de Hematología
Zonas de especial interés y actividades
Tratamiento e investigación en LLC
Mostrar másMedical Fields of Interest:
Chronic Leukemia (Chronic Lymphocytes Leukemia/ Chronic Myeloid Leukemia)
Chronic Myeloproliferative Diseases (Polistemia Vera, Essential Thrombocytosis, Myelofibrosis etc.)
Lymphoma (Hodgkin’s and Non-Hodgkin’s)
Multiple Myeloma
Education:
Ege University Faculty of Medicine Medical Doctor 1999 - 2005
Pamukkale University Specialist in Internal Medicine 2006 - 2011
Pamukkale University Hematologist 2011 - 2014
ESCCA Summer School On Cytometry/PRAGUE (May 2014)
Istanbul Training and Research Hospital Hematology Clinic Associate Professor 2018
Experience:
Selçuk University Faculty of Medicine Hospital 2015
Pamukkale University Internal Medicine Residency Training 2016-2011
Denizli Sarayköy State Hospital 2011-2011
Pamukkale University Hematology Minor Residency Training 2011-2014
Istanbul Training and Research Hospital Hematology Clinic Specialist Doctor 2015-2020
Istanbul Training and Research Hospital Hematology Clinic Responsible Authority 2015-2020
Istanbul Training and Research Hospital Hematology Clinic Responsible Authority/ Lecturer 2019-2020
Istanbul Başakşehir Çam and Şakura City Hospital Hematology Clinic Lecturer 2020-2020
Liv Hospital Ulus 2020-
Memberships:
Turkish Society of Hematology
The Society of Hematological Education and Research (Member of The Board of Directors
Mostrar másEl Dr. Dror Levin es pediatra principal y director de los departamentos de tratamiento de trastornos sanguíneos y cáncer de huesos (sarcoma) en el Hospital Infantil "Dana" y el Centro Médico "Sourasky", respectivamente. Es especialista en medicina pediátrica, hematología y oncología, con experiencia adicional estudiando en el extranjero en el Instituto Ortopédico Rizzoli en Italia.
Mostrar másacreditaciones:
Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.
His medical interests include:
Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)
Acute Leukemia
Chronic Leukemia Treatments
Hodgkin Lymphoma
Non-Hodgkin Lymphoma Treatments
Multiple Myeloma Treatments, MDS
Aplastic Anemia
ITP
TTP Treatments
Hypercoagulability
Hereditary Thrombophilia Treatments
Therapeutic Apheresis
Photopheresis
Geriatric Hematology Diseases.
Mostrar más- El Dr. Francesc Bosch está especializado en técnicas innovadoras de quimioterapia para la leucemia.
- Emplea métodos como terapia dirigida, inmunoterapia y quimioterapia combinada.
- La formación internacional incluye una beca en la Universidad de Columbia, Nueva York.
- Reconocido por liderar más de 80 ensayos clínicos y promover tratamientos para la leucemia.
- Catedrático de Hematología, centrado en la investigación de la Leucemia Linfocítica Crónica.
- Miembro del grupo español para el estudio de CLL, potenciando protocolos de tratamiento.
- Fluido en inglés y español, facilitando consultas integrales a los pacientes.
acreditaciones:
El Prof. Moshe Inbar es un oncólogo israelí y Jefe del Departamento de Oncología del Centro Médico Sourasky (Ichilov), que se especializa en cáncer de mama, cáncer de útero y ovarios, cáncer urogenital en mujeres y hombres, y cáncer gastrointestinal. Es profesor asociado clínico en la Universidad de Tel Aviv, posee numerosos premios y es miembro de varias organizaciones de investigación.
Mostrar más